SCHEMBL6166453

SCHEMBL6166453

CN(C)c1ccc(-c2nn(CCC#N)c3c2C(=O)CC3)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.39
MAPT P10636 3/20 0.39
GAA P10253 1/20 0.39
KMT2A Q03164 7/20 0.38
MEN1 O00255 5/20 0.38
NPC1 O15118 1/20 0.38
CRHBP P24387 1/20 0.38
RAB9A P51151 1/20 0.38
CRHR2 Q13324 1/20 0.38
CASP1 P29466 5/20 0.37
CASP7 P55210 5/20 0.37
USP2 O75604 4/20 0.37
CYP1A2 P05177 4/20 0.37
HSD17B10 Q99714 4/20 0.37
CYP2D6 P10635 3/20 0.37
HIF1A Q16665 3/20 0.37
HPGD P15428 3/20 0.37
TSHR P16473 1/20 0.37
CYP2C19 P33261 1/20 0.36
BRCA1 P38398 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6167036 0.83 RIPK3 (0.39) ALDH1A1MAPTKMT2AHPGDSLC34A1
SCHEMBL6164086 0.75 ALDH1A1 (0.36) ALDH1A1MAPTGAAKMT2AMEN1
SCHEMBL6165490 0.74 LMNA (0.49) ALDH1A1MAPTGAAKMT2AMEN1
SCHEMBL6165983 0.74 ATM (0.44) ALDH1A1MAPTGAAKMT2ACYP1A2
SCHEMBL6166254 0.74 ALDH1A1 (0.38) ALDH1A1MAPTGAAKMT2AMEN1
SCHEMBL6167558 0.74 BRD4 (0.31) BRD4CREBBPEP300
SCHEMBL6163581 0.70 CYP1A2 (0.36) ALDH1A1MAPTKMT2AMEN1CASP1
SCHEMBL6164339 0.69 HTT (0.34) BRD4CREBBPEP300
SCHEMBL6165037 0.68 MAOB (0.42) ALDH1A1MAPTGAAKMT2AMEN1
SCHEMBL6164169 0.68 HTT (0.48) ALDH1A1KMT2AMEN1HSD17B10CREBBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1177185-B1 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA ITALIA SPA (IT) 2005-04-20 EP disclosed
US-6716856-B1 CELL PROLIFERATIVE DISORDERS OR ALZHEIMER'S DISEASE; REDUCED TOXICITY; CDK/CYCLIN KINASE INHIBITORY ACTIVITY PHARMACIA & TUBJOHN SPA (IT) 2004-04-06 US disclosed